Nov 9 (Reuters) – Hims & Hers Health on Monday narrowed its annual revenue forecast to a range below Wall Street estimates as gross margins contracted amid its expansion into branded weight-loss drugs and international markets.
The company now expects 2026 revenue of $3.13 billion to $3.15 billion, compared with its previous forecast of $3.1 billion to $3.3 billion. Analysts expect $3.21 billion, according to data compiled by LSEG.
(Reporting by Kunal Das in Bengaluru; Editing by Sahal Muhammed)
